Mayne Pharma Responds to Cosette’s Claims as Scheme Discussions Continue.

Mayne Pharma Group Limited (ASX: MYX) has provided an update regarding its ongoing Scheme of Arrangement with Cosette Pharmaceuticals. Cosette previously claimed a Mayne Material Adverse Change had occurred, potentially triggering specific clauses in their Scheme Implementation Deed (SID). However, Mayne Pharma clarified that the 10-day consultation period has ended without any notice of termination from Cosette, although the right to terminate remains available until the Second Court Date.

Mayne Pharma maintains that no Material Adverse Change has occurred and has reserved its rights under the SID, including the possibility of legal action if required. Additionally, Mayne received a close-out letter from the FDA confirming resolution of prior regulatory issues. The company continues to support the successful completion of the scheme, urging shareholders to review the Scheme Booklet and vote accordingly. Mayne remains committed to protecting shareholder interests throughout this process.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com